The FDA’s REMS Restriction limits access to Self-Managed Abortions (SMAs)
3 min readSep 22, 2022
--
Did you know that the FDA has a restriction called the Risk Evaluation and Mitigation Strategy (“REMS”) for mifepristone — 1 of the 2 drugs used for self-managed abortions (SMAs) or medication abortions in early pregnancy?
The FDA previously announced its intention to exercise enforcement discretion for the in-person dispensing requirement…